The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Open accessAbstract
Luteolin, 3',4',5,7-tetrahydroxyflavone, is a common flavonoid that exists in many types of plants including fruits, vegetables, and medicinal herbs. Plants rich in luteolin have been used in Chinese traditional medicine for treating various diseases such as hypertension, inflammatory disorders, and cancer. Having multiple biological effects such as anti-inflammation, anti-allergy and anticancer, luteolin functions as either an antioxidant or a pro-oxidant biochemically. The biological effects of luteolin could be functionally related to each other. For instance, the anti-inflammatory activity may be linked to its anticancer property. Luteolin's anticancer property is associated with the induction of apoptosis, and inhibition of cell proliferation, metastasis and angiogenesis. Furthermore, luteolin sensitizes cancer cells to therapeutic-induced cytotoxicity through suppressing cell survival pathways such as phosphatidylinositol 3'-kinase (PI3K)/Akt, nuclear factor kappa B (NF-kappaB), and X-linked inhibitor of apoptosis protein (XIAP), and stimulating apoptosis pathways including those that induce the tumor suppressor p53. These observations suggest that luteolin could be an anticancer agent for various cancers. Furthermore, recent epidemiological studies have attributed a cancer prevention property to luteolin. In this review, we summarize the progress of recent research on luteolin, with a particular focus on its anticancer role and molecular mechanisms underlying this property of luteolin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Advances in flavonoid research since 1992
Harborne, J. B., & Williams, C. A. (2000) · Phytochemistry · doi:10.1016/s0031-9422(00)00235-1 · Cited by 3,956
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Antioxidant and Prooxidant Behavior of Flavonoids: Structure-Activity Relationships
Cao, G., Sofic, E., & Prior, R. L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00351-6 · Cited by 2,415
(2001) · PubMed · Cited by 2,381
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
D IETARY F LAVONOIDS: Bioavailability, Metabolic Effects, and Safety
Ross, J. A., & Kasum, C. M. (2002) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.22.111401.144957 · Cited by 2,151
Flavonoids: antioxidants or signalling molecules?
Williams, R. J., Spencer, J. P. E., & Rice-Evans, C. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.01.001 · Cited by 2,016
Matrix metalloproteinases and tumor metastasis
Deryugina, E. I., & Quigley, J. P. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7886-9 · Cited by 1,960
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Miean, K. H., & Mohamed, S. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf000892m · Cited by 1,371
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
G1 cell-cycle control and cancer
Massagué, J. (2004) · Nature · doi:10.1038/nature03094 · Cited by 1,224
Dietary agents in cancer prevention: flavonoids and isoflavonoids
Birt, D. F., Hendrich, S., & Wang, W. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00137-1 · Cited by 1,171
Matrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
Galati, G., & O'Brien, P. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.034 · Cited by 1,099
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
The correlation between active oxygens scavenging and antioxidative effects of flavonoids
Hanasaki, Y., Ogawa, S., & Fukui, S. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90202-x · Cited by 951
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
Dietary Flavonoids and the Risk of Lung Cancer and Other Malignant Neoplasms
Knekt, P., J rvinen, R., Sepp nen, R., Heli vaara, M., Teppo, L., Pukkala, E., & Aromaa, A. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009257 · Cited by 771
The antitumor activities of flavonoids.
Kandaswami, C. C., Kanadaswami, C., Lee, L., Lee, P.-P. H., Hwang, J.-J., Ke, F., Huang, Y.-T., & Lee, M. (2005) · PubMed · Cited by 758
Cancer preventive effects of flavonoids—a review
Le Marchand, L. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00186-5 · Cited by 583
Kim, H. K., Cheon, B. S., Kim, Y. H., Kim, S. Y., & Kim, H. P. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00160-4 · Cited by 546
Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis.
Fotsis, T., Pepper, M. S., Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wähälä, K., Montesano, R., & Schweigerer, L. (1997) · PubMed · Cited by 534
Galati, G. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00198-1 · Cited by 529
Quantitative structure-activity relationship analysis of phenolic antioxidants
Lien, E. J., Ren, S., Bui, H.-H., & Wang, R. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00190-7 · Cited by 528
Redox-dependent downregulation of Rho by Rac
Nimnual, A. S., Taylor, L. J., & Bar-Sagi, D. (2003) · Nature Cell Biology · doi:10.1038/ncb938 · Cited by 515
Beuvink, I., Boulay, A., Fumagalli, S., Zilbermann, F., Ruetz, S., O’Reilly, T., Natt, F., Hall, J., Lane, H. A., & Thomas, G. (2005) · Cell · doi:10.1016/j.cell.2004.12.040 · Cited by 486
Brusselmans, K., Vrolix, R., Verhoeven, G., & Swinnen, J. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408177200 · Cited by 474
Protein kinase C inhibition by plant flavonoids
Ferriola, P. C., Cody, V., & Middleton, E. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90309-2 · Cited by 450
Review: Dietary Flavonoids and Cancer Risk: Evidence From Human Population Studies
Neuhouser, M. L. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc5001_1 · Cited by 449
Intestinal absorption of luteolin and luteolin 7‐O‐β‐glucoside in rats and humans
Shimoi, K., Okada, H., Furugori, M., Goda, T., Takase, S., Suzuki, M., Hara, Y., Yamamoto, H., & Kinae, N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01304-0 · Cited by 418
Wright, M. E. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh173 · Cited by 401
Inhibition of Xanthine Oxidase by Flavonoids
NAGAO, A., SEKI, M., & KOBAYASHI, H. (1999) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.63.1787 · Cited by 385
Tumour necrosis factor-α as a tumour promoter
Szlosarek, P., Charles, K. A., & Balkwill, F. R. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.012 · Cited by 366
Chen, C.-Y., Peng, W.-H., Tsai, K.-D., & Hsu, S.-L. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.09.028 · Cited by 358
Murkies, A. L., Wilcox, G., & Davis, S. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4577 · Cited by 355
Genistein arrests cell cycle progression at G2-M.
Matsukawa, Y., Marui, N., Sakai, T., Satomi, Y., Yoshida, M., Matsumoto, K., Nishino, H., & Aoike, A. (1993) · PubMed · Cited by 340
IMPACT OF CELLULAR METABOLISM ON THE BIOLOGICAL EFFECTS OF BENZO[A]PYRENE AND RELATED HYDROCARBONS†
Miller, K. P., & Ramos, K. S. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-100000138 · Cited by 332
Luteolin-rich artichoke extract protects low density lipoprotein from oxidation In vitro
Brown, J. E., & Rice-Evans, C. A. (1998) · Free Radical Research · doi:10.1080/10715769800300281 · Cited by 330
Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes
Wang, C., Mäkelä, T., Hase, T., Adlercreutz, H., & Kurzer, M. S. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90030-2 · Cited by 322
Antioxidant Activities of Different Colored Sweet Bell Peppers ( Capsicum annuum L.)
Sun, T., Xu, Z., Wu, C. ‐., Janes, M., Prinyawiwatkul, W., & No, H. K. (2007) · Journal of Food Science · doi:10.1111/j.1750-3841.2006.00245.x · Cited by 310
Casagrande, F., & Darbon, J.-M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00583-4 · Cited by 303
Xagorari, A., Papapetropoulos, A., Mauromatis, A., Economou, M., Fotsis, T., & Roussos, C. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29679-8 · Cited by 297
Exploring a New Twist on Tumor Metastasis
Yang, J., Mani, S. A., & Weinberg, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3850 · Cited by 297
A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer
Gates, M. A., Tworoger, S. S., Hecht, J. L., De Vivo, I., Rosner, B., & Hankinson, S. E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22790 · Cited by 295
Genistein arrests cell cycle progression at G2-M
松川, 義. (1995) · Medical Entomology and Zoology · Cited by 295
p53 modulation of the DNA damage response
Helton, E. S., & Chen, X. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21091 · Cited by 293
JNK Suppresses Apoptosis via Phosphorylation of the Proapoptotic Bcl-2 Family Protein BAD
Yu, C., Minemoto, Y., Zhang, J., Liu, J., Tang, F., Bui, T. N., Xiang, J., & Lin, A. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00028-0 · Cited by 290
Huang, Y. ‐., Hwang, J. ‐., Lee, P. ‐., Ke, F. ‐., Huang, J. ‐., Huang, C. ‐., Kandaswami, C., Middleton, E., & Lee, M. ‐. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702879 · Cited by 287
Buening, M. K., Chang, R. L., Huang, M., Fortner, J. G., Wood, A. W., & Conney, A. H. (1981) · PubMed · Cited by 287
Sugihara, N., Arakawa, T., Ohnishi, M., & Furuno, K. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00167-7 · Cited by 284
Cytotoxicity of Flavonoids toward Cultured Normal Human Cells
Matsuo, M., Sasaki, N., Saga, K., & Kaneko, T. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.253 · Cited by 253
Osakabe, N. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh034 · Cited by 236
Sergedien≐, E., Jönsson, K., Szymusiak, H., Tyrakowska, B., Rietjens, I. M. C. M., & Č≐nas, N. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01561-6 · Cited by 234
Cancer Chemoprevention and Apoptosis Mechanisms Induced by Dietary Polyphenolics
Galati, Teng, Moridani, Chan, & O'Brien (2000) · Drug Metabolism and Drug Interactions · doi:10.1515/dmdi.2000.17.1-4.311 · Cited by 225
Flavonoids activate wild-type p53.
Plaumann, B., Fritsche, M., Rimpler, H., Brandner, G., & Hess, R. D. (1996) · PubMed · Cited by 223
Lin, Y., Devin, A., Cook, A., Keane, M. M., Kelliher, M., Lipkowitz, S., & Liu, Z.-G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6638-6645.2000 · Cited by 222
Self-citationSelvendiran, K., Koga, H., Ueno, T., Yoshida, T., Maeyama, M., Torimura, T., Yano, H., Kojiro, M., & Sata, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4062 · Cited by 217
Steroid hormone activity of flavonoids and related compounds
Zand, R. S. R., Jenkins, D. J. A., & Diamandis, E. P. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006422302173 · Cited by 217
State of the Art. Chronic Obstructive Pulmonary Disease, Inflammation, and Lung Cancer
Brody, J. S., & Spira, A. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-089ms · Cited by 215
Effect of flavonoids on cell cycle progression in prostate cancer cells
Kobayashi, T., Nakata, T., & Kuzumaki, T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00738-8 · Cited by 214
Bagli, E., Stefaniotou, M., Morbidelli, L., Ziche, M., Psillas, K., Murphy, C., & Fotsis, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3104 · Cited by 213
Cytotoxic drugs and the CD95 pathway
Friesen, C., Fulda, S., & Debatin, K.-M. (1999) · Leukemia · doi:10.1038/sj.leu.2401333 · Cited by 208
Bioflavonoid interaction with rat uterine type ii binding sites and cell growth inhibition
Markaverich, B. M., Roberts, R. R., Alejandro, M. A., Johnson, G. A., Middleditch, B. S., & Clark, J. H. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90078-7 · Cited by 203
Radioprotective effect of antioxidative flavonoids in γ-ray irradiated mice
Shimoi, K., Masuda, S., Furugori, M., Esaki, S., & Kinae, N. (1994) · Carcinogenesis · doi:10.1093/carcin/15.11.2669 · Cited by 198
Lupu, R., & Menendez, J. (2006) · Current Pharmaceutical Biotechnology · doi:10.2174/138920106779116928 · Cited by 196
Huang, M.-T., Wood, A. W., Newmark, H. L., Sayer, J. M., Yagi, H., Jerina, D. M., & Conney, A. H. (1983) · Carcinogenesis · doi:10.1093/carcin/4.12.1631 · Cited by 195
Antioxidant and Prooxidant Effects of Phenolics on Pancreatic β-Cells in Vitro
Lapidot, T., Walker, M. D., & Kanner, J. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf020615a · Cited by 195
Epithelial NF-κB activation promotes urethane-induced lung carcinogenesis
Stathopoulos, G. T., Sherrill, T. P., Cheng, D.-S., Scoggins, R. M., Han, W., Polosukhin, V. V., Connelly, L., Yull, F. E., Fingleton, B., & Blackwell, T. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705316104 · Cited by 187
Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells
Hu, C., & Kitts, D. D. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000044364.73144.fe · Cited by 187
Lim, D. Y., Jeong, Y., Tyner, A. L., & Park, J. H. Y. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00248.2006 · Cited by 186
Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I
CHOWDHURY, A. R., SHARMA, S., MANDAL, S., GOSWAMI, A., MUKHOPADHYAY, S., & MAJUMDER, H. K. (2002) · Biochemical Journal · doi:10.1042/bj20020098 · Cited by 185
Inhibition of LPS‐stimulated pathways in macrophages by the flavonoid luteolin
Xagorari, A., Roussos, C., & Papapetropoulos, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704803 · Cited by 181
Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells
Horinaka, M., Yoshida, T., Shiraishi, T., Nakata, S., Wakada, M., Nakanishi, R., Nishino, H., Matsui, H., & Sakai, T. (2005) · Oncogene · doi:10.1038/sj.onc.1208874 · Cited by 180
Phytoestrogens as modulators of steroid action in target cells
Benassayag, C., Perrot-Applanat, M., & Ferre, F. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00340-9 · Cited by 180
Lee, L.-T., Huang, Y.-T., Hwang, J.-J., Lee, P. H., Ke, F., Nair, M. P. N., Kanadaswam, C., & Lee, M. (2002) · PubMed · Cited by 176
Wruck, C. J., Claussen, M., Fuhrmann, G., Römer, L., Schulz, A., Pufe, T., Waetzig, V., Peipp, M., Herdegen, T., & Götz, M. E. (2007) · Neuropsychiatric Disorders An Integrative Approach · doi:10.1007/978-3-211-73574-9_9 · Cited by 176
Elangovan, V., Sekar, N., & Govindasamy, S. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90416-2 · Cited by 174
Kim, J. S., & Jobin, C. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02156.x · Cited by 173
Lansky, E. P., Harrison, G., Froom, P., & Jiang, W. G. (2005) · Investigational New Drugs · doi:10.1007/s10637-005-5856-7 · Cited by 171
Han, D.-H., Denison, M. S., Tachibana, H., & Yamada, K. (2002) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.66.1479 · Cited by 171
Lee, H.-J., Wang, C.-J., Kuo, H.-C., Chou, F.-P., Jean, L.-F., & Tseng, T.-H. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.08.004 · Cited by 168
Harris, G. K., Qian, Y., Leonard, S. S., Sbarra, D. C., & Shi, X. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1517 · Cited by 165
Zi, X., Feyes, D. K., & Agarwal, R. (1998) · PubMed · Cited by 164
Flavonoids Suppress Androgen-Independent Human Prostate Tumor Proliferation
Knowles, L. M., Zigrossi, D. A., Tauber, R. A., Hightower, C., & Milner, J. A. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc381_16 · Cited by 161
KOTANIDOU, A., XAGORARI, A., BAGLI, E., KITSANTA, P., FOTSIS, T., PAPAPETROPOULOS, A., & ROUSSOS, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2101049 · Cited by 161
Ju, W., Wang, X., Shi, H., Chen, W., Belinsky, S. A., & Lin, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032185 · Cited by 156
Self-citationLuteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells
Fang, J., Zhou, Q., Shi, X., & Jiang, B. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl189 · Cited by 149
Collins‐Burow, B. M., Burow, M. E., Duong, B. N., & McLachlan, J. A. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc382_13 · Cited by 149
Veeriah, S., Kautenburger, T., Habermann, N., Sauer, J., Dietrich, H., Will, F., & Pool‐Zobel, B. L. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20158 · Cited by 148
Kumazawa, Y., Kawaguchi, K., & Takimoto, H. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778743565 · Cited by 148
Monasterio, A., Urdaci, M. C., Pinchuk, I. V., López-Moratalla, N., & Martínez-Irujo, J. J. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc5001_12 · Cited by 146
Flavonol and flavone intake and the risk of cancer in male smokers (Finland)
Hirvonen, T., Virtamo, J. R. K., Korhonen, P. A., Albanes, D., & Pietinen, P. (2001) · Cancer Causes & Control · doi:10.1023/a:1012232008016 · Cited by 145
Shen, S., Ko, C. H., Tseng, S.-W., Tsai, S.-H., & Chen, Y. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.02.002 · Cited by 133
Structure-activity studies of flavonoids as inhibitors of hyaluronidase
Kuppusamy, U. R., Khoo, H. E., & Das, N. P. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90709-t · Cited by 131
Lee, W.-J., Wu, L.-F., Chen, W.-K., Wang, C., & Tseng, T. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.01.002 · Cited by 131
García-Closas, R., Agudo, A., Gonzalez, C. A., & Ríboli, E. (1998) · Nutrition and Cancer · doi:10.1080/01635589809514734 · Cited by 128
Huang, C., Huang, Y., Li, J., Hu, W., Aziz, R. M., Tang, M.-S., Sun, N.-J., Cassady, J. M., & Stoner, G. D. (2002) · PubMed · Cited by 124
Triterpene, Antioxidant, and Antimicrobial Compounds from Melissa officinalis
Mencherini, T., Picerno, P., Scesa, C., & Aquino, R. P. (2007) · Journal of Natural Products · doi:10.1021/np070351s · Cited by 124
Samy, R. P., Gopalakrishnakone, P., & Ignacimuthu, S. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.08.018 · Cited by 121
Leung, H. W.-C., Kuo, C., Yang, W., Lin, C.-H., & Lee, H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.021 · Cited by 120
Belyanskaya, L. L., Hopkins-Donaldson, S., Kurtz, S., Simões‐Wüst, A. P., Yousefi, S., Simon, H., Stahel, R. A., & Zangemeister‐Wittke, U. (2005) · International Journal of Cancer · doi:10.1002/ijc.21242 · Cited by 113
Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin
Yamashita, N., & Kawanishi, S. (2000) · Free Radical Research · doi:10.1080/10715760000301141 · Cited by 113
Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells
Shi, R., Ong, C. N., & Shen, H. (2004) · Oncogene · doi:10.1038/sj.onc.1208046 · Cited by 112
Self-citationGrowth Inhibitory Effects of Flavonoids in Human Thyroid Cancer Cell Lines
Yin, F., Giuliano, A. E., & Herle, A. J. V. (1999) · Thyroid · doi:10.1089/thy.1999.9.369 · Cited by 111
Chang, J., Hsu, Y., Kuo, P., Kuo, Y.-C., Chiang, L., & Lin, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.11.003 · Cited by 107
Shi, R., Huang, Q., Zhu, X., Ong, Y. B., Zhao, B., Lu, J., Ong, C. N., & Shen, H. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0638 · Cited by 105
Self-citationShi, R., Ong, C. N., & Shen, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3875 · Cited by 104
Self-citationChiu, F., & Lin, J. (2007) · The Prostate · doi:10.1002/pros.20690 · Cited by 103
Protein kinase C involvement in apoptosis
Lucas, M., & Sánchez‐Margalet, V. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)00295-x · Cited by 102
Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells
Chen, D., Chen, M. S., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Frontiers in bioscience · doi:10.2741/2199 · Cited by 101
Oral Grape Seed Extract Inhibits Prostate Tumor Growth and Progression in TRAMP Mice
Raina, K., Singh, R. P., Agarwal, R., & Agarwal, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0295 · Cited by 100
Inhibitory Effect of Perilla Leaf Extract and Luteolin on Mouse Skin Tumor Promotion.
Ueda, H., Yamazaki, C., & Yamazaki, M. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.560 · Cited by 96
Inhibition of Matrix Metalloproteinase-2 and -9 Activities by Selected Flavonoids
Ende, C., & Gebhardt, R. (2004) · Planta Medica · doi:10.1055/s-2004-832630 · Cited by 96
Induction of apoptosis by luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells
Cheng, A., Huang, T., Lai, C., & Pan, M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.026 · Cited by 95
Lee, L.-T., Huang, Y.-T., Hwang, J.-J., Lee, A. Y.-L., Ke, F., Huang, C., Kandaswami, C. C., Lee, P.-P. H., & Lee, M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.023 · Cited by 95
Ise, R., Han, D., Takahashi, Y., Terasaka, S., Inoue, A., Tanji, M., & Kiyama, R. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.033 · Cited by 94
Robak, J., Shridi, F., Wolbiś, M., & Królikowska, M. (1988) · PubMed · Cited by 87
Estrogen, Estrogen Plus Progestin Therapy, and Risk of Breast Cancer
Colditz, G. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.909s.11.2 · Cited by 79
TRAIL resistance results in cancer progression: a TRAIL to perdition?
Malhi, H., & Gores, G. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209765 · Cited by 74
Chiang, C.-T., Way, T., & Lin, J. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0107 · Cited by 71
Protective role of luteolin in 1,2‐dimethylhydrazine induced experimental colon carcinogenesis
Vaiyapuri, M., & Nalini, N. (2006) · Cell Biochemistry and Function · doi:10.1002/cbf.1305 · Cited by 68
Lu, H., Li, J., Zhang, D., Stoner, G. D., & Huang, C. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5401_8 · Cited by 67
Mitogen activated protein kinases as targets for development of novel anti-inflammatory drugs
Karin, M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.028274 · Cited by 66
Devasagayam, T. P. A., Subramanian, M., Singh, B. B., Ramanathan, R., & Das, N. P. (1995) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/1011-1344(95)07159-y · Cited by 63
Chan, T. S., Galati, G., Pannala, A. S., Rice-Evans, C. A., & O'Brien, P. J. (2003) · Free Radical Research · doi:10.1080/1071576031000094899 · Cited by 63
Karrasch, T., Kim, J., Jang, B. I., & Jobin, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000596 · Cited by 60
Antioxidants and inhibitor of matrix metalloproteinase-1 expression from leaves ofzostera marina L.
Kim, J. H., Cho, Y. H., Park, S. M., Lee, K. E., Lee, J. J., Lee, B. C., Pyo, H.-B., Song, K. S., Park, H. D., & Yun, Y. P. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980103 · Cited by 58
Huang, Y.-T., Lee, L.-T., Lee, P. H., Lin, Y., & Lee, M. (2005) · PubMed · Cited by 58
Self-citationHasebe, Y., Egawa, K., Yamazaki, Y., Kunimoto, S., Hirai, Y., Ida, Y., & Nose, K. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.1379 · Cited by 56
Treatment of Corneal Neovascularization with Dietary Isoflavonoids and Flavonoids
Joussen, A. M., Rohrschneider, K., Reichling, J., Kirchhof, B., & Kruse, F. E. (2000) · Experimental Eye Research · doi:10.1006/exer.2000.0900 · Cited by 55
Törmäkangas, L., Vuorela, P. M., Saario, E., Leinonen, M., Saikku, P., & Vuorela, H. J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.07.012 · Cited by 53
Trochon-Joseph, V., Mabilat, C., Bertrand, P., Legrand, Y., Soria, J., Soria, C., Delpech, B., & Lu, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01337-9 · Cited by 50
KIM, J., LEE, E., Lee, H., KU, J., LEE, M., Yang, D., & KIM, S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.102_2 · Cited by 45
Li, J., Zhang, D., Stoner, G. D., & Huang, C. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20377 · Cited by 44
Caino, M. C., Oliva, J. L., Jiang, H., Penning, T. M., & Kazanietz, M. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.032078 · Cited by 39
Chemopreventive potential of luteolin during colon carcinogenesis induced by 1,2-dimethylhydrazine.
Vaiyapuri, M., & Nalini, N. (2005) · PubMed · Cited by 38
Sen, N., Das, B. B., Ganguly, A., Banerjee, B., Sen, T., & Majumder, H. K. (2006) · Experimental Parasitology · doi:10.1016/j.exppara.2006.03.013 · Cited by 37
Estrone-induced cell proliferation and differentiation in the mammary gland of the female Noble rat
Holland, M. B., & Roy, D. (1995) · Carcinogenesis · doi:10.1093/carcin/16.8.1955 · Cited by 19
Reconstitution of the type II [3H]estradiol binding site with recombinant histone H4
Shoulars, K., Rodriguez, M. A., Crowley, J. R., TURK, J. W., Thompson, T., & Markaverich, B. M. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.11.009 · Cited by 8
Cited by
Kinase-targeted cancer therapies: progress, challenges and future directions
Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0804-2 · Cited by 1,245
Luteolin, a flavonoid, as an anticancer agent: A review
Imran, M., Rauf, A., Abu-Izneid, T., Nadeem, M., Shariati, M. A., Khan, I. A., Imran, A., Orhan, I. E., Rizwan, M., Atif, M., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108612 · Cited by 931
Pasupuleti, V. R., Sammugam, L., Ramesh, N., & Gan, S. H. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1259510 · Cited by 917
Heavy metal associated health hazards: An interplay of oxidative stress and signal transduction
Paithankar, J. G., Saini, S., Dwivedi, S., Sharma, A., & Chowdhuri, D. K. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2020.128350 · Cited by 589
Ferreira, J. F. S., Luthria, D. L., Sasaki, T., & Heyerick, A. (2010) · Molecules · doi:10.3390/molecules15053135 · Cited by 531
Metadata
- Authors
- Lin, Y., Shi, R., Wang, X., & Shen, H.-M.
- Venue
- Current Cancer Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-11-01
- Volume
- 8
- Issue
- 7
- Pages
- 634-646
- ISSN
- 1568-0096 (ISSN-L)
- OpenAlex
- W2109069677
- Cited by
- 1,169
- References
- 144
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.